{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:48:14Z","timestamp":1792601294683,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The obesity paradox is reported to exist in various diseases. However, obesity is a pivotal issue in gastric cancer (GC) patients because of the surgical difficulty related to postoperative abdominal infectious complications (PAIC). This study clarified the existence of the obesity paradox in GC. Between 1997 and 2015, 1536 consecutive patients underwent curative gastrectomy. Of all patients, 18.6% (285\/1536) were obese and tended to have a better prognosis (<jats:italic>P<\/jats:italic>\u2009=\u20090.073). In patients without PAIC, obesity was a significant prognostic factor for 5-year overall survival (<jats:italic>P<\/jats:italic>\u2009=\u20090.017). PAIC was an independent poor prognostic factor in both obese and non-obese patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; hazard ratio [HR] 4.22 and 1.82). In pStage II\u2013III patients, there was a large and significant prognostic difference between non-PAIC and PAIC obese patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.006; 5-year overall survival: 69.7% vs. 43.8%) related to the higher incidence of peritoneal recurrence in PAIC obese patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.035; 31% vs. 10%). Whereas, there was a small prognostic difference between non-PAIC and PAIC non-obese patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.102; 5-year overall survival: 56.5% vs. 51.9%). Although the obesity paradox is present in GC, PAIC had a more negative prognostic impact through peritoneal recurrence in obese GC patients.<\/jats:p>","DOI":"10.1038\/s41598-023-36968-7","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:03:24Z","timestamp":1687367004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Obesity paradox as a new insight from postoperative complications in gastric cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Hajime","family":"Kamiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nishibeppu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eigo","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"36968_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"36968_CR2","unstructured":"The Foundation for Promotion of Cancer Research (FPCR). Cancer Statistics in JAPAN 2018. (2018)."},{"key":"36968_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","author":"J Ferlay","year":"2021","unstructured":"Ferlay, J. et al. Cancer statistics for the year 2020: An overview. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.33588 (2021).","journal-title":"Int. J. Cancer"},{"key":"36968_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10120-015-0500-5","volume":"19","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. et al. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: A meta-analysis. Gastric Cancer 19, 543\u2013552. https:\/\/doi.org\/10.1007\/s10120-015-0500-5 (2016).","journal-title":"Gastric Cancer"},{"key":"36968_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.sla.0000225364.03133.f8","volume":"245","author":"S Kitano","year":"2007","unstructured":"Kitano, S., Shiraishi, N., Uyama, I., Sugihara, K. & Tanigawa, N. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann. Surg. 245, 68\u201372. https:\/\/doi.org\/10.1097\/01.sla.0000225364.03133.f8 (2007).","journal-title":"Ann. Surg."},{"key":"36968_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0140-6736(10)61121-x","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang, Y. J. et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 376, 687\u2013697. https:\/\/doi.org\/10.1016\/s0140-6736(10)61121-x (2010).","journal-title":"Lancet"},{"key":"36968_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ags3.12284","volume":"3","author":"S Komatsu","year":"2019","unstructured":"Komatsu, S. & Otsuji, E. Essential updates 2017\/2018: Recent topics in the treatment and research of gastric cancer in Japan. Ann Gastroenterol Surg 3, 581\u2013591. https:\/\/doi.org\/10.1002\/ags3.12284 (2019).","journal-title":"Ann Gastroenterol Surg"},{"key":"36968_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/s0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng, M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: A systematic analysis for the global burden of disease study 2013. Lancet 384, 766\u2013781. https:\/\/doi.org\/10.1016\/s0140-6736(14)60460-8 (2014).","journal-title":"Lancet"},{"key":"36968_CR9","unstructured":"World Health Organization, W. (Fact sheet N\u00b0 311, 2015: URL: http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/) (2015)."},{"key":"36968_CR10","doi-asserted-by":"publisher","first-page":"e1003198","DOI":"10.1371\/journal.pmed.1003198","volume":"17","author":"H Dai","year":"2020","unstructured":"Dai, H. et al. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990\u20132017: An analysis of the global burden of disease study. PLoS Med. 17, e1003198. https:\/\/doi.org\/10.1371\/journal.pmed.1003198 (2020).","journal-title":"PLoS Med."},{"key":"36968_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2012.113905","volume":"309","author":"KM Flegal","year":"2013","unstructured":"Flegal, K. M., Kit, B. K., Orpana, H. & Graubard, B. I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309, 71\u201382. https:\/\/doi.org\/10.1001\/jama.2012.113905 (2013).","journal-title":"JAMA"},{"key":"36968_CR12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/s2213-8587(18)30288-2","volume":"6","author":"K Bhaskaran","year":"2018","unstructured":"Bhaskaran, K., Dos-Santos-Silva, I., Leon, D. A., Douglas, I. J. & Smeeth, L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3\u00b76 million adults in the UK. Lancet Diabetes Endocrinol 6, 944\u2013953. https:\/\/doi.org\/10.1016\/s2213-8587(18)30288-2 (2018).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"36968_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1245\/s10434-006-9209-3","volume":"14","author":"T Tsujinaka","year":"2007","unstructured":"Tsujinaka, T. et al. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann. Surg. Oncol. 14, 355\u2013361. https:\/\/doi.org\/10.1245\/s10434-006-9209-3 (2007).","journal-title":"Ann. Surg. Oncol."},{"key":"36968_CR14","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1007\/s00464-011-1798-7","volume":"25","author":"K Yoshikawa","year":"2011","unstructured":"Yoshikawa, K. et al. Visceral fat area is superior to body mass index as a predictive factor for risk with laparoscopy-assisted gastrectomy for gastric cancer. Surg. Endosc. 25, 3825\u20133830. https:\/\/doi.org\/10.1007\/s00464-011-1798-7 (2011).","journal-title":"Surg. Endosc."},{"key":"36968_CR15","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00464-008-0247-8","volume":"23","author":"C Kunisaki","year":"2009","unstructured":"Kunisaki, C. et al. Predictive factors for surgical complications of laparoscopy-assisted distal gastrectomy for gastric cancer. Surg. Endosc. 23, 2085\u20132093. https:\/\/doi.org\/10.1007\/s00464-008-0247-8 (2009).","journal-title":"Surg. Endosc."},{"key":"36968_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1245\/s10434-013-3384-9","volume":"21","author":"T Kubota","year":"2014","unstructured":"Kubota, T. et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann. Surg. Oncol. 21, 891\u2013898. https:\/\/doi.org\/10.1245\/s10434-013-3384-9 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"36968_CR17","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-012-2720-9","volume":"20","author":"M Tokunaga","year":"2013","unstructured":"Tokunaga, M., Tanizawa, Y., Bando, E., Kawamura, T. & Terashima, M. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann. Surg. Oncol. 20, 1575\u20131583. https:\/\/doi.org\/10.1245\/s10434-012-2720-9 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"36968_CR18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s10147-016-0987-8","volume":"21","author":"J Kiuchi","year":"2016","unstructured":"Kiuchi, J. et al. Putative risk factors for postoperative pneumonia which affects poor prognosis in patients with gastric cancer. Int. J. Clin. Oncol. 21, 920\u2013926. https:\/\/doi.org\/10.1007\/s10147-016-0987-8 (2016).","journal-title":"Int. J. Clin. Oncol."},{"key":"36968_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ags3.12002","volume":"1","author":"H Shimada","year":"2017","unstructured":"Shimada, H., Fukagawa, T., Haga, Y. & Oba, K. Does postoperative morbidity worsen the oncological outcome after radical surgery for gastrointestinal cancers? A systematic review of the literature. Ann Gastroenterol Surg 1, 11\u201323. https:\/\/doi.org\/10.1002\/ags3.12002 (2017).","journal-title":"Ann Gastroenterol Surg"},{"key":"36968_CR20","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1002\/cam4.2439","volume":"8","author":"M Kanda","year":"2019","unstructured":"Kanda, M. et al. Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer. Cancer Med 8, 5194\u20135201. https:\/\/doi.org\/10.1002\/cam4.2439 (2019).","journal-title":"Cancer Med"},{"key":"36968_CR21","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625\u20131638. https:\/\/doi.org\/10.1056\/NEJMoa021423 (2003).","journal-title":"N. Engl. J. Med."},{"key":"36968_CR22","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00268-012-1582-4","volume":"36","author":"B Kayani","year":"2012","unstructured":"Kayani, B. et al. Does obesity affect outcomes in patients undergoing esophagectomy for cancer? A meta-analysis. World J. Surg. 36, 1785\u20131795. https:\/\/doi.org\/10.1007\/s00268-012-1582-4 (2012).","journal-title":"World J. Surg."},{"key":"36968_CR23","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3945\/ajcn.116.136531","volume":"104","author":"V Walter","year":"2016","unstructured":"Walter, V. et al. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer. Am. J. Clin. Nutr. 104, 1110\u20131120. https:\/\/doi.org\/10.3945\/ajcn.116.136531 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"36968_CR24","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/jnci\/djt310","volume":"105","author":"AA Hakimi","year":"2013","unstructured":"Hakimi, A. A. et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J. Natl. Cancer Inst. 105, 1862\u20131870. https:\/\/doi.org\/10.1093\/jnci\/djt310 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"36968_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","volume":"6","author":"G Kichenadasse","year":"2020","unstructured":"Kichenadasse, G. et al. Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer. JAMA Oncol. 6, 512\u2013518. https:\/\/doi.org\/10.1001\/jamaoncol.2019.5241 (2020).","journal-title":"JAMA Oncol."},{"key":"36968_CR26","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1245\/s10434-009-0645-8","volume":"16","author":"M Tokunaga","year":"2009","unstructured":"Tokunaga, M. et al. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann. Surg. Oncol. 16, 3245\u20133251. https:\/\/doi.org\/10.1245\/s10434-009-0645-8 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"36968_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1440-1746.2008.05704.x","volume":"24","author":"SJ Oh","year":"2009","unstructured":"Oh, S. J. et al. Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma. J. Gastroenterol. Hepatol. 24, 475\u2013479. https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05704.x (2009).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"36968_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ejso.2010.07.007","volume":"36","author":"J Kulig","year":"2010","unstructured":"Kulig, J. et al. Implications of overweight in gastric cancer: A multicenter study in a Western patient population. Eur. J. Surg. Oncol. 36, 969\u2013976. https:\/\/doi.org\/10.1016\/j.ejso.2010.07.007 (2010).","journal-title":"Eur. J. Surg. Oncol."},{"key":"36968_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1245\/s10434-012-2653-3","volume":"20","author":"KA Bickenbach","year":"2013","unstructured":"Bickenbach, K. A. et al. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann. Surg. Oncol. 20, 780\u2013787. https:\/\/doi.org\/10.1245\/s10434-012-2653-3 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"36968_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.cmet.2013.05.008","volume":"17","author":"D Mathis","year":"2013","unstructured":"Mathis, D. Immunological goings-on in visceral adipose tissue. Cell Metab. 17, 851\u2013859. https:\/\/doi.org\/10.1016\/j.cmet.2013.05.008 (2013).","journal-title":"Cell Metab."},{"key":"36968_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","volume":"11","author":"T Deng","year":"2016","unstructured":"Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A. & Hsueh, W. A. Obesity, inflammation, and cancer. Annu. Rev. Pathol. 11, 421\u2013449. https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044359 (2016).","journal-title":"Annu. Rev. Pathol."},{"key":"36968_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cyto.2013.07.017","volume":"64","author":"MK Gunasekaran","year":"2013","unstructured":"Gunasekaran, M. K. et al. Inflammation triggers high mobility group box 1 (HMGB1) secretion in adipose tissue, a potential link to obesity. Cytokine 64, 103\u2013111. https:\/\/doi.org\/10.1016\/j.cyto.2013.07.017 (2013).","journal-title":"Cytokine"},{"key":"36968_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mce.2017.06.012","volume":"454","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. HMGB1, an innate alarmin, plays a critical role in chronic inflammation of adipose tissue in obesity. Mol. Cell. Endocrinol. 454, 103\u2013111. https:\/\/doi.org\/10.1016\/j.mce.2017.06.012 (2017).","journal-title":"Mol. Cell. Endocrinol."},{"key":"36968_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063264","author":"W Takaki","year":"2022","unstructured":"Takaki, W. et al. Role of extracellular high-mobility group box-1 as a therapeutic target of gastric cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23063264 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"36968_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00595-010-4371-4","volume":"41","author":"A Osoegawa","year":"2011","unstructured":"Osoegawa, A. et al. Plasma high-mobility group box 1 as an indicator of surgical stress. Surg. Today 41, 903\u2013907. https:\/\/doi.org\/10.1007\/s00595-010-4371-4 (2011).","journal-title":"Surg. Today"},{"key":"36968_CR36","doi-asserted-by":"publisher","first-page":"6513","DOI":"10.21873\/anticanres.13016","volume":"38","author":"K Katsurahara","year":"2018","unstructured":"Katsurahara, K. et al. Relationship between postoperative CRP and prognosis in thoracic esophageal squamous cell carcinoma. Anticancer Res. 38, 6513\u20136518. https:\/\/doi.org\/10.21873\/anticanres.13016 (2018).","journal-title":"Anticancer Res."},{"key":"36968_CR37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s10147-019-01580-1","volume":"25","author":"D Matsubara","year":"2020","unstructured":"Matsubara, D. et al. The impact of postoperative inflammation on recurrence in patients with colorectal cancer. Int. J. Clin. Oncol. 25, 602\u2013613. https:\/\/doi.org\/10.1007\/s10147-019-01580-1 (2020).","journal-title":"Int. J. Clin. Oncol."},{"key":"36968_CR38","doi-asserted-by":"publisher","unstructured":"Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24, 1-21, doi:https:\/\/doi.org\/10.1007\/s10120-020-01042-y (2021).","DOI":"10.1007\/s10120-020-01042-y"},{"key":"36968_CR39","doi-asserted-by":"publisher","unstructured":"New criteria for 'obesity disease' in Japan. Circ J 66, 987-992, doi:https:\/\/doi.org\/10.1253\/circj.66.987 (2002).","DOI":"10.1253\/circj.66.987"},{"key":"36968_CR40","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36968-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36968-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36968-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:05:42Z","timestamp":1687367142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36968-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36968"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36968-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10116"}}